文献速递乳腺癌放疗

列线图预测局部区域复发以辅助T1-2N1乳腺癌患者乳房切除术后放疗决策

Nomogram Predicting Locoregional Recurrence to Assist Decision-Making of Postmastectomy Radiation Therapy in Patients With T1-2N1 Breast Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-11-10

该回顾性研究纳入2001年1月至2012年12月间接受乳房切除术的1141例T1-2N1乳腺癌患者,基于623例未放疗患者的Fine和Gray竞争风险回归构建预测局部区域复发的列线图,并通过决策树分析将患者分为3个风险组。中位随访74.9个月,高危组接受乳房切除术后放疗与5年局部区域复发风险降低12.7%、远处复发风险降低9.2%、乳腺癌死亡率降低7.0%相关,而低危和中危组无显著关联。

要点

  • 基于623例未放疗患者的竞争风险模型构建列线图,实现T1-2N1乳腺癌局部区域复发的个体化风险量化。
  • 决策树分析将患者分为3个风险组,高危组接受乳房切除术后放疗与5年局部区域复发风险降低12.7%相关。
  • 低危和中危组中乳房切除术后放疗与局部区域复发、远处复发或乳腺癌死亡率无显著关联。

核心结论

  • 列线图可对T1-2N1乳腺癌患者的局部区域复发进行个体化风险量化,新识别的高危亚组可从乳房切除术后放疗中获得生存获益。

研究设计与样本

  • 回顾性分析1141例2001年1月至2012年12月间接受乳房切除术的T1-2N1乳腺癌患者,基于623例未放疗患者的Fine和Gray竞争风险回归构建列线图,采用决策树分析进行患者分组。

主要发现

  • 全队列中位随访74.9个月,5年局部区域复发累积发生率为3.9%,远处复发为8.8%,乳腺癌死亡率为6.0%。
  • 高危组接受乳房切除术后放疗与5年局部区域复发风险降低12.7%、5年远处复发风险降低9.2%、5年乳腺癌死亡率降低7.0%相关。
  • 低危和中危组中乳房切除术后放疗与局部区域复发、远处复发或乳腺癌死亡率无显著关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Postmastectomy radiation therapy (PMRT) had heterogeneous effects on survival outcome of patients with T1-2N1 breast cancer. A reliable model to estimate individuals' risk of locoregional recurrence (LRR) and the potential benefit derived from PMRT is needed. METHODS AND MATERIALS: We retrospectively analyzed 1141 patients with T1-2N1 breast cancer who underwent mastectomy between January 2001 and December 2012. Based on the Fine and Gray competing risks regression in 623 unirradiated patients, a nomogram predicting LRR was conducted for risk quantification. Decision tree analysis was performed for patient grouping. The impact of PMRT was evaluated among 3 subgroups. RESULTS: With a median follow-up of 74.9 months, the 5-year cumulative incidence of LRR, distant recurrence (DR) and breast cancer mortality (BCM) were 3.9%, 8.8%, and 6.0%, respectively, for the entire cohort. Based on nomogram scores, patients were classified into 3 risk groups in decision tree analysis. In the high-risk group, PMRT was found to be associated with a 12.7% risk reduction of 5-year LRR, 9.2% risk reduction of 5-year DR, and 7.0% risk reduction of 5-year BCM, whereas it was not significantly associated with LRR, DR, or BCM in low- and intermediate-risk groups. CONCLUSIONS: The nomogram performed individualized risk quantification of LRR in patients with T1-2N1 breast cancer. A newly identified patient subgroup with high risk of LRR were found to derive survival benefit from PMRT.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Luo C, Zhong X, Deng L, et al. Nomogram Predicting Locoregional Recurrence to Assist Decision-Making of Postmastectomy Radiation Therapy in Patients With T1-2N1 Breast Cancer. Int J Radiat Oncol Biol Phys. 2018. PMID: 30419307. doi:10.1016/j.ijrobp.2018.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。